Company Filing History:
Years Active: 1977-1978
Title: Bernard J Ludwig: Innovator in Anti-Inflammatory Compounds
Introduction
Bernard J Ludwig is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods and compounds aimed at suppressing histamine release and providing anti-inflammatory effects.
Latest Patents
Ludwig holds 2 patents that showcase his innovative approaches. His first patent is titled "Method for suppressing histamine release." This method involves administering specific compounds to warm-blooded animals to suppress histamine release from sensitized leukocytes. The compounds are characterized by a formula that includes various chemical components, ensuring effective results in the targeted suppression of histamine.
His second patent, "2,3,4,4A-Tetrahydro-10H-1,2-oxazino[3,2-b](1,3)benzoxazin-10-ones," describes chemical compounds that exhibit valuable anti-inflammatory activity in standard laboratory animals. These compounds are defined by a formula that allows for various substitutions, enhancing their therapeutic potential.
Career Highlights
Bernard J Ludwig has had a distinguished career, primarily working with Carter Wallace, Inc. His work has focused on the development of pharmaceutical innovations that address critical health issues related to inflammation and allergic responses.
Collaborations
Throughout his career, Ludwig has collaborated with esteemed colleagues, including David B Reisner and Frank M Berger. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Bernard J Ludwig's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving health outcomes. His work continues to influence the development of effective treatments for inflammation and allergic reactions.